Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Oil, LNG Prices Climb on Fears of Prolonged Hormuz Shutdown March 3, 2026 Vale CEO: Real Assets Gaining Traction as Money Shifts Away from Tech March 3, 2026 Outstanding Antimony Results at Casablanca March 3, 2026